Health News Roundup: Drug retailer Rite Aid files for bankruptcy, gets $3.45 billion commitment; EU delays approval of Novavax's revised COVID vaccine

Following is a summary of current health news briefs.

Drug retailer Rite Aid files for bankruptcy, gets $3.45 billion commitment

Rite Aid filed for Chapter 11 bankruptcy on Sunday, a move that would halt lawsuits the drugstore chain is facing over its alleged role in the U.S. opioid crisis and named a new CEO.

Rite Aid said it has received a commitment for $3.45 billion in new financing from some of its lenders, which will provide enough liquidity to support it through the bankruptcy process.

EU delays approval of Novavax's revised COVID vaccine

European Union (EU) regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the company said on Sunday. The European Medicines Agency (EMA) has requested more information from Novavax on the shot, which targets the XBB variant, the company said.